XETRA - Delayed Quote EUR
Novo Nordisk A/S (NOV.DE)
57.69
-1.56
(-2.63%)
As of 2:07:34 PM GMT+2. Market Open.
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in DKK | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 8 | 8 | 24 | 24 |
Avg. Estimate | 77.79B | 83.22B | 338.42B | 391.11B |
Low Estimate | 73.62B | 78.03B | 318.21B | 353.69B |
High Estimate | 81.46B | 86.5B | 361.02B | 423.44B |
Year Ago Sales | 68.06B | 71.31B | 290.4B | 338.42B |
Sales Growth (year/est) | 14.29% | 16.70% | 16.54% | 15.57% |
EPS Trend
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
NOV.DE | -- | -- | -- | -- |
S&P 500 | 13.21% | 3.06% | 8.01% | 13.77% |
Related Tickers
NOVN.SW Novartis AG
88.70
-2.43%
BAYN.DE Bayer Aktiengesellschaft
24.07
+0.08%
SAN.PA Sanofi
87.47
-1.72%
ROG.SW Roche Holding AG
247.80
-3.80%
LLY.F Eli Lilly and Company
638.70
-3.56%
PFE.DE Pfizer Inc.
19.60
-1.90%
LLY.DE Eli Lilly and Company
638.70
-4.51%
GRF.MC Grifols, S.A.
8.15
+0.27%
LLY Eli Lilly and Company
734.57
-2.25%
JNJ.DE Johnson & Johnson
135.26
-2.10%